The Valley Desk

ArticleRegulatory toxicology and pharmacology : RTPPublished

The use of total versus unbound exposures for reporting safety margins during drug development: An IQ consortium analysis of pharmaceutical industry practice

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Regulatory toxicology and pharmacology : RTP
Published
Subject terms
Animals; Humans; Risk Assessment; Toxicity Tests; Drug Industry; Drug Development; Safety Margin; Plasma Protein Binding; Nonclinical Safety; Unbound Exposure; Exposure Margin; Free-drug Exposure
PubMed ID
42092493
Added to directory
Source checked

Report a correction or request removal